tailieunhanh - Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Selecting the appropriate patients to receive immunotherapy (IO) remains a challenge due to the lack of optimal biomarkers. The presence of liver metastases has been implicated as a poor prognostic factor in patients with metastatic cancer. | Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN